Home › Head and Neck Squamous Cell Carcinoma › Texas › Irving
Head and Neck Squamous Cell Carcinoma clinical trials in Irving, TX
6 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #73, Irving
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology - Dallas, Irving
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
RecruitingPhase 1
- Next Oncology Dallas /ID# 276659, Irving
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- US Oncology Investigational Product Center (IPC), Irving
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- Next Oncology Dallas /ID# 276254, Irving
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecruitingPhase 1
- NEXT Texas LLC - Dallas, Irving
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- Nashville, TN39 studies
- New York City, NY39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Chicago, IL26 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- Pittsburgh, PA22 studies
- New Haven, CT22 studies
Other studies in Irving
- Non-Small Cell Lung Cancer22 studies
- Cancer (all types)15 studies
- Colorectal Cancer13 studies
- Metastatic Cancer11 studies
- Pancreatic Cancer7 studies
- Stomach Cancer7 studies
- Breast Cancer6 studies
- Small Cell Lung Cancer6 studies
- Lung Cancer6 studies
- Ovarian Cancer5 studies
- Endometrial Cancer4 studies
- Prostate Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.